Sara Eyal
Overview
Explore the profile of Sara Eyal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mills J, Romagnolo A, Battaglia G, Eyal S, Gulcebi M, Macrohon B, et al.
Epilepsia
. 2024 Dec;
66(2):341-345.
PMID: 39636217
No abstract available.
2.
3.
4.
Cohen H, Bahash N, Raccah B, Matok I, Ekstein D, Goldstein L, et al.
Epilepsia
. 2024 Oct;
65(12):3474-3483.
PMID: 39460651
No abstract available.
5.
Tepper-Shimshon O, Tetro N, Hamed R, Erenburg N, Merquiol E, Dey G, et al.
Pharmaceutics
. 2024 Sep;
16(9).
PMID: 39339247
The space environment can affect the function of all physiological systems, including the properties of cell membranes. Our goal in this study was to explore the effect of simulated microgravity...
6.
7.
8.
Mahajna M, Abu Fanne R, Odeh M, Berkovitch M, Tannous E, Eyal S, et al.
Front Pharmacol
. 2024 Mar;
15:1358549.
PMID: 38440181
Tramadol is primarily metabolized by the highly polymorphic enzyme, leading to a large spectrum of adverse events and clinical response. Ample evidence pointed a reduced CYPD26 activity score in individuals...
9.
Hamed R, Merquiol E, Zlotver I, Blum G, Eyal S, Ekstein D
ACS Omega
. 2024 Feb;
9(6):6965-6975.
PMID: 38371846
Our goal was to test the feasibility of a new theranostic strategy in chronic epilepsy by targeting cathepsin function using novel cathepsin activity-based probes (ABPs). We assessed the biodistribution of...
10.
Cohen H, Mahajna G, Ben-Shushan T, Matok I, Eyal S
Epilepsia
. 2023 Nov;
65(2):445-455.
PMID: 38010146
Objective: Antiseizure medications (ASMs) are commonly categorized as enzyme-inducers and non-enzyme-inducers based on their propensity to enhance the metabolism of concomitantly administered drugs. This systematic review and network meta-analysis aimed...